FDA.reportPublic FDA data

HYPROMELLOSE PHTHALATE (31% PHTHALATE, 170 CST)

Substance profile for UNII 8LDD2V82F5, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
8LDD2V82F5
Preferred term
HYPROMELLOSE PHTHALATE (31% PHTHALATE, 170 CST)
Registry number
9050-31-1
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
1368891
PubChem
0
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1368891https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1368891
FDA Substance Registration System8LDD2V82F5https://precision.fda.gov/uniisearch/srs/unii/8LDD2V82F5

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
HYPROMELLOSE PHTHALATE (31% PHTHALATE, 170 CST)INACTIVE INGREDIENT8LDD2V82F5These highlights do not include all the information needed to use ZENPEP safely and effectively. See full prescribing information for ZENPEP. ZENPEP ® (pancrelipase) delayed release capsules Initial U.S. Approval: 20091
hypromellose phthalate (31% phthalate, 170 cst)INACTIVE INGREDIENT8LDD2V82F5These highlights do not include all the information needed to use Aggrenox Capsules safely and effectively. See full prescribing information for Aggrenox Capsules. AGGRENOX® (aspirin/extended-release dipyridamole) Capsules Initial U.S. Approval: 19992
hypromellose phthalate (31% phthalate, 170 cst)INACTIVE INGREDIENT8LDD2V82F5These highlights do not include all the information needed to use Aggrenox Capsules safely and effectively. See full prescribing information for Aggrenox Capsules. AGGRENOX® (aspirin/extended-release dipyridamole) Capsules Initial U.S. Approval: 19991
HYPROMELLOSE PHTHALATE (31% PHTHALATE, 170 CST)INACTIVE INGREDIENT8LDD2V82F5Drug Facts3
HYPROMELLOSE PHTHALATE (31% PHTHALATE, 170 CST)INACTIVE INGREDIENT8LDD2V82F5ZENPEP (PANCRELIPASE) CAPSULE, DELAYED RELEASE [APTALIS PHARMA US, INC.]17
HYPROMELLOSE PHTHALATE (31% PHTHALATE, 170 CST)INACTIVE INGREDIENT8LDD2V82F5PANCRELIPASE CAPSULE, DELAYED RELEASE [X-GEN PHARMACEUTICALS, INC.]14
HYPROMELLOSE PHTHALATE (31% PHTHALATE, 170 CST)INACTIVE INGREDIENT8LDD2V82F5OMEPRAZOLE CAPSULE, DELAYED RELEASE [ZYDUS PHARMACEUTICALS (USA) INC.]5
HYPROMELLOSE PHTHALATE (31% PHTHALATE, 170 CST)INACTIVE INGREDIENT8LDD2V82F5ASPIRIN ENTERIC COATED (REGULAR STRENGTH ASPIRIN) TABLET [CHAIN DRUG CONSORTIUM]2
HYPROMELLOSE PHTHALATE (31% PHTHALATE, 170 CST)INACTIVE INGREDIENT8LDD2V82F5ASPIRIN AND DIPYRIDAMOLE CAPSULE [TEVA PHARMACEUTICALS USA INC]1
HYPROMELLOSE PHTHALATE (31% PHTHALATE, 170 CST)INACTIVE INGREDIENT8LDD2V82F5OMEPRAZOLE CAPSULE, DELAYED RELEASE [CADILA HEALTHCARE LIMITED]1